These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2510724

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
    Maragoudakis ME, Wasvary J, Hankin H, Gargiulo P.
    Mol Pharmacol; 1984 May; 25(3):425-30. PubMed ID: 6427599
    [Abstract] [Full Text] [Related]

  • 3. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF, Kinoshita JH, Tung WH, Chylack LT.
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interrelationships among human aldo-keto reductases: immunochemical, kinetic and structural properties.
    Srivastava SK, Das B, Hair GA, Gracy RW, Awasthi S, Ansari NH, Petrash JM.
    Biochim Biophys Acta; 1985 Jul 05; 840(3):334-43. PubMed ID: 3924115
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Placental aldose reductase inhibition by Silybin (preliminary communication).
    Santos J, Mira LB, Freire AM, Azevedo M, Manso C.
    Acta Med Port; 1984 Jul 05; 5(4-5):115-7. PubMed ID: 6431756
    [No Abstract] [Full Text] [Related]

  • 8. Aldose reductase localization in human retinal mural cells.
    Akagi Y, Kador PF, Kuwabara T, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1983 Nov 05; 24(11):1516-9. PubMed ID: 6417042
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Purification of aldose reductase from human placenta and stabilization of the inhibitor binding site.
    Vander Jagt DL, Stangebye LA, Hunsaker LA, Eaton RP, Sibbitt WL.
    Biochem Pharmacol; 1988 Mar 15; 37(6):1051-6. PubMed ID: 3128293
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE, Lai CJ.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):89-97. PubMed ID: 8615700
    [Abstract] [Full Text] [Related]

  • 15. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF, Sharpless NE.
    Mol Pharmacol; 1983 Nov 01; 24(3):521-31. PubMed ID: 6415401
    [Abstract] [Full Text] [Related]

  • 16. [The characteristics of aldose reductase in human lens, placenta, and rat organs (author's transl)].
    Yoshida H.
    Nippon Ganka Gakkai Zasshi; 1981 Aug 10; 85(8):865-9. PubMed ID: 6797273
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Purification and partial characterization of peroxidase from human term placenta of non-smokers: metabolism of benzo(a)pyrene-7, 8-dihydrodiol.
    Madhavan ND, Naidu KA.
    Placenta; 2000 Aug 10; 21(5-6):501-9. PubMed ID: 10940200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.